Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KalMo: Lopinavir/ritonavir Monotherapy Maintenance in HIV
NCT00160849Phase 4Completed
- Sponsor
- Federal University of Rio de Janeiro
- Start
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lopinavir + ritonavir in human immunodeficiency virus infection (HIV), sponsored by Federal University of Rio de Janeiro. Started Aug 2004; status: completed.
02
Drugs
lopinavir + ritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00160849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00160849.